Schedule of the conference
Day 1: Wednesday, June 6th 2018
17:00 – 19:00 Special pre workshop tutorial
By Ali Madani, Managing Partner of Avicenne Medical, Founder of IMPLANTS event
Ali Madani’s tutorials feature among the most highly rated presentations by participants. Come on Wednesday afternoon and benefit from Avicenne’s latest market research based on 25 years of experience and extensive business connections with all parties (Orthopaedic companies, CMOs, Surgeons, PE funds, etc).
This session has limited seat availability, its format has been designed for an interactive session with Ali Madani. This 2 hours session is packed with information, to which you can react in real time. You will hear about:
1. Orthopaedics market perspectives and main issues
2. Contract Manufacturing markets, trends and player strategies
Day 2: Thursday, June 7th 2018
8:30 – 9:00 Welcome desk – registration
Supply chain and contract manufacturing
9:00 – 9:25 Ali MADANI, Chief Executive Officer & Founder, Avicenne, France
9:25 – 9:50 Mark KEMP, President & Chief Executive Officer, Tecomet, USA
Partnership Innovation is Happening Now
- Are the major OEMs relying more on contract manufacturing?
- What are the top needs of the orthopedic OEMs… One-stop shopping, shared responsibilities, co-invention and co-development agreements?
- Key growth factors and barriers to development for orthopedics “Solutions Providers”
9:50 – 10:15 Jerry JURKIEWICZ, Chief Executive Officer, Orchid Orthopedic Solutions, USA
Strategy in the changing Contract Manufacturing landscape
- Industry heavy trends
- Orchid positioning & strategy
- Conclusions: the future of Orthopaedic Contract manufacturing, lessons for the future
10:15 - 10:45 Coffee-break & Networking
10:45 – 11:10 Mark MORRISON, Manager, Materials Research and Tribology, Smith & Nephew, USA
Applications of Additive Manufacturing in the Orthopaedic Industry:
- The use of additive manufacturing is growing in key applications
- Application selection is critical for the creation of value
- Advantages and disadvantages of AM need to be evaluated for each potential application
11:10 – 11:35 Ali KIAPOUR, Senior Principal R&D Engineer, 4WEB Medical Inc., USA
3D printing pure players : exception or way to go?
- FDA and regulations for additive manufactured medical devices
- Current challenges and limitations of the additive manufacturing
- Emerging technologies in additive manufacturing process
- 3D printing of biological tissues
- Process improvement strategies and techniques
11:35 – 12:00 Magnus RENÉ, Former Chief Executive Officer, ARCAM, Sweden
Additive Manufacturing for orthopaedics: from niche market to the mass market!
- Will additive manufacturing be a key technology for the orthopaedics industry in the years to come? For which products & which applications?
- Which users? Additive Manufacturing for implants will be used mainly by orthopaedic companies or contract manufacturing organizations ?
- Additive Manufacturing applications for orthopaedic Instruments
- Additive Manufacturing: Raw materials issues
12:00 – 12:25 Pierfrancesco ROBOTTI, Scientific Marketing Manager, Eurocoating, Italy
Use of Additive Manufacturing in the serial production of titanium based Orthopaedic Implants:
- Designed for AM Serial Production
- Material performances across different building strategy
- Operations during serial additive manufacturing
- Quality, cleaning and post processes
12:30 - 14:00 Lunch & networking
Quality & Regulatory
14:00 – 14:25 Daniel DELFOSSE, Head of Innovation & Technology, Mathys Ltd Bettlach, Switzerland
The impact of the new Medical Devices Regulatory on innovations: How high will the hurdles be?
- Regulatory threats and uncertainties for innovative ideas
- Cost and timeline to bring innovations to the market
- Need for technical documentation from subcontractors
- Timely communication with the Notified Body
14:25 – 14:50 Diarmuid DE FAOITE, Global Clinical Strategy Manager, Smith & Nephew, Switzerland
Dynamic tools to measure health outcomes after an orthopaedic surgery:
- Theory: IRT v traditional PROs
- Development of Smith & Nephew app
- First results
- Outlook (incl. future wound app)
14:50 – 15:15 Stefano ADAMI, Senior consultant, Confinis, Switzerland
Dealing with Innovation and costs In Orthopedics: how can regulatory and quality tasks become more cost-effective?
- Introduction on upcoming Regulatory and Quality challenges including main changes for the Orthopedic Sector
- Streamline of Quality and Regulatory activities in the value chain
- How to plan for cost-effective Regulatory and Quality tasks
- How to manage the increased regulatory burdens
Robotic assisted & Navigation
14:00 – 14:25 Sébastien HENRY, Founder & CEO, Pixee Médical, France
Where is consensus on robotics for orthopaedics ? Is it the right candidate for a standard of care?
- A growing installed based and a strong commitments from the Majors
- Surgeons needs and real expectations
- Are Augmented Realty or Virtual Realty the right candidates for mass market and standard of care ?
- Other affordable and efficient solutions to answer better the surgeon needs
14:25 – 14:50 Manuel FUENTES, Regional Business Manager, Robotics and Total Joint Replacements, Eastern USA, OMNIlife science, USA
Robotic-assisted surgery in orthopaedics: fact or fad?
- Resistance toward Robotics development
- What it is the expected value of Robotics today and in the future?
- Results from field studies and consulting bodies
- Magnitude of the market and competitive landscape
- What is OMNIlife robotic solution bringing to the market?
- Is robotics a game changer in orthopaedics?
14:50 – 15:15 Speaker to be confirmed
15:15 - 15:55 Coffee-break & Networking
Disruptive innovations, Emerging technologies & Markets
15:55 – 16:20 Andrew T. ROCK, Co-founder of K2M Group, Board member and Consultant for several Medtech companies, USA
Evolution of the Spine Industry, Past Present and Future: “A behind the Scenes Perspective”
- Mid 80s to early 90s
Lift off and Stage 1 of growth
IPOs and Mergers that almost happened &
Mergers that created Depuy Motech
- Late 90s
The Cage Rage and Rage against the cage
Balloons and Biomaterials delivery
MIS focused companies emerge
Mega Mergers mega growth
Back to the future
- 2010 US Market disruption and adaptation to AHC
- Future of a Mature Spine Market
Steps to successful commercialization in changing global regulatory and financial environment.
16:20 – 16:45 David PELIZZON, President, Squadron Capital, USA
Integrating Supply and Finance – A New Model For Growth:
- What are the financial Challenges Facing Start-up and Smaller Orthopedic Companies?
- Weighting the top 4 requirements for success:
- Create Product or service differentiation
- Demonstrate Operational and financial leadership
- Build a sound Supplier relationship
- Secure Adequate financing
- Structure Medical innovative Integrations of Supply and Finance
- Its Impact to Valuation
- A brief Case study
16:45 – 17:10 Nicolas PIVERT, Country Director, Restorative Therapies Group, Medtronic, France
Pathways for innovation in the orthopaedic field: beyond products
- What can be considered as genuine innovation in orthopaedic / Spinal surgery today?
- Incremental vs disruptive innovation
- How to overcome innovation hurdles today?
- How is the healthcare system shaping future orthopaedic innovations?
17:10 – 17:35 Mauro MALZANNI, Strategy and Marketing Director – Emerging Markets and Asia Pacific, Smith & Nephew, UAE
Changes and dynamics within the Emerging Markets for the orthopaedic industry:
- The key emerging markets and their characteristics (China, India, South America)
- Opportunities and challenges to consider to achieve market penetration
- Barriers to entry and strategies to overcome local specificities
17:35 – 18:00 Lane HALE, President & CEO, ECA Medical Instruments, USA and James B. SCHULTZ, Executive Vice President Sales & Marketing, ECA Medical Instruments, USA
Single-Procedure Instrument & Procedural Kit Advancements & Opportunities for Orthopaedic & Spine
- The goal: One Instrument, One Patient at a Time
- The problem of pain (industry woes and paradigm shifts)
- Application of single-procedure instrumentation (stand alone & procedural kits)
- Clinical benefits of surgery ready single-procedure instrumentation (and implants) to hospitals and outpatient surgical centers
- Business benefits of sterile-pack, surgery-ready instrumentation to Ortho / Spine stakeholders
- What the future holds for mass market adoption (logistics/fulfillment, global reach & impact, personalized medicine and more)